“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z

A venture capitalist discusses his shift from a large biotech fund to a smaller AI-focused investment firm, and explains how AI is transforming biology from discovery to engineering. This reflects how AI is increasingly reshaping real-world industries and funding decisions.